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High blood pressure is the most powerful contributor to the cardiovascular morbidity and mortality, and inverse correlation
between consumption of polyphenol-rich foods or beverages and incidence of cardiovascular diseases gains more importance.
Reactive oxygen species plays an important role in the development of hypertension. We found that wild thyme (a spice plant,
rich in polyphenolic compounds) induced a significant decrease of blood pressure and vascular resistance in hypertensive rats.
The inverse correlation between vascular resistance and plasma heme oxygenase-1 suggests that endogenous vasodilator carbon
monoxide generated by heme oxidation could account for this normalization of blood pressure. Next product of heme oxidation,
bilirubin (a chain-breaking antioxidant that acts as a lipid peroxyl radical scavenger), becomes significantly increased after wild
thyme treatment and induces the reduction of plasma lipid peroxidation in hypertensive, but not in normotensive rats.The obtained
results promote wild thyme as useful supplement for cardiovascular interventions.
1. Introduction
High blood pressure is certainly the most prevalent and
powerful contributor to the cardiovascular morbidity and
mortality in the majority of industrialized countries, with
essential hypertension accounting for about 95% of all cases
of hypertension [1]. Hypertension is recognized as a highly
significant risk factor, and many effective antihyperten-
sive drugs are developed, including angiotensin convert-
ing enzyme inhibitors, angiotensin-II receptor antagonists,
diuretics, beta blockers, calcium channels blockers, and nitric
oxide (NO) donors [2, 3].
Yet, for various reasons, hypertension is still a poorly
controlled disorder, even in countries with very efficient
preventive medical services. At the same time, about 75
to 80% of the world population (particularly in developing
countries) uses alternative treatment options, often herbal
medicines for the treatment of various health problems [4].
It should also be noted that there is a growing body of evi-
dence suggesting the effectiveness of alternative therapeutic
approaches in the treatment of various disorders, including
hypertension. Thus, epidemiological evidence suggests the
existence of a negative correlation between consumption
of polyphenol-rich foods (fruits, vegetables, cocoa, etc.) or
beverages (wine, especially red wine, grape juice, tea, etc.)
and the incidence of cardiovascular disease [5, 6]. Thymus
serpyllum L. (wild thyme, TE) has traditionally been used as a
spice plant, whose aqueous extract is rich in the polyphenolic
compounds [7] that are considered to be responsible for
their antioxidant effects. Also, the antihypertensive effect of
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essential oils from Chinese medicinal plants was confirmed
in experimental studies [8]. Similarly, water extracts of plants
from Lamiaceae family, rich in phenolic acids, decreased
systolic blood pressure after subcutaneous administration
in conscious stroke-prone spontaneously hypertensive rats
[9] and inhibit rabbit lung angiotensin I-converting enzyme
in vitro [10]. In addition, our previous study showed that
aqueous extract obtained from TE induces powerful NO-
independent systemic vasodilatation in spontaneously hyper-
tensive rats (SHR) [7].
On the other hand, it is well known that reactive oxygen
species (ROS), amongst other factors, play an important role
in the development of hypertension in many experimental
models, as well as in patients with essential, renovascular,
and malignant hypertension [11]. Several experiments in
which the expression of heme oxygenase-1 (HO-1), inducible
form of the rate-limiting enzyme in the degradation of
heme [12], was upregulated by different modulators or by
gene transfer suggested that HO-1 participates in defence
mechanisms against agents that induce oxidative injury [13].
Heme oxygenase cleaves the heme ring to form the water-
soluble 1-carbon fragment as carbon monoxide (CO), iron,
and a biliverdin [14], which is reduced by biliverdin reductase
to bilirubin (lipophilic linear tetrapyrrole), a compound
with potent antioxidant capacity, abundant in blood plasma
[15]. Further studies confirmed the circulating forms of
bilirubin, such as free bilirubin, albumin-bound bilirubin,
conjugated bilirubin, and unconjugated bilirubin as effective
scavengers of peroxyl radicals able to protect human low-
density lipoprotein against peroxidation [13]. The CO, gener-
ated in equimolar concentrations to biliverdin during heme
oxidation by HO, like NO, inhibits platelet aggregation and
acts as a vasodilatorwhen bioavailability ofNO is limited [16].
This relaxation of vascular smooth muscle cells results from
activation of pathways, including the stimulation of soluble
guanylyl cyclase, opening of calcium activated K+ channel,
inhibition of cytochrome P450-dependent monooxygenase,
or blocking the production of constrictor substances like
endothelin [17]. Furthermore, the increased ROS production
that was observed in hypertensive animals and humans could
be reduced by treatment with superoxide dismutase (SOD)
mimetics or antioxidants, resulting in the improvement of
vascular and renal function, regression of vascular remod-
elling, and reduction of blood pressure [11]. Considering all
the above, we hypothesized that TE regulates blood pressure
and oxidative stress of SHR through a mechanism that could
involve HO-1.
Therefore, the aim of the present study was to evaluate
the ability of TE treatment to upregulate the expression and
activity of inducible form of HO-1 and its correlation with
antihypertensive as well as antioxidant responses of SHR.
2. Material and Methods
2.1.Thyme Extract Preparation. Dry thyme extract (TE) from
Thymus serpyllum L. was prepared as described previously
[7]. Briefly, TE was extracted by pouring 200mL of boiled
distilled water over the herbal samples (10 g) at room tem-
perature, filtered through a tea strainer, and freeze-dried.
The yield of freeze-dried TE amounted to 1.67% (w/w).
The total polyphenols content of the corresponding freeze-
dried TE exhibited 20.08mg GAE/100mg of TE, while the
HPLC analysis of the polyphenolic profile of the obtained
extract showed rosmarinic (4.30mg/100mg of freeze-dried
TE) and caffeic acids (0.08mg/100mg of freeze-dried TE)
as predominant TE phenols. The antioxidant capacity of
TE evaluated by the FRAP and ABTS assays amounted
to 1.66mmol Fe(II)/100mg and 86.1 𝜇mol Trolox/100mg of
freeze-dried TE, respectively. As the dose-dependent antihy-
pertensive evaluations revealed only the dose of 100mg/kg
freeze-dried TE effective in reducing systolic blood pressure
[7], the present study was carried out with this TE dose.
2.2. Animals. We used six-month-old male spontaneously
hypertensive rats (SHR, descendants of breeders originally
obtained through Taconic Farms, Germantown, NY, USA)
and normotensive Wistar (W) rats, bred at the Institute for
Medical Research, University of Belgrade, Serbia, weighing
about 300 g. They were maintained in temperature and
humidity controlled rooms on a twelve-hour light-dark cycle.
The experimental protocol was approved by the Ethic
Committee of the Institute for Medical Research, University
of Belgrade, Serbia (number 0312-1/10), according to the
National Law on Animal Welfare.
Rats were divided in 4 groups: two control groups,
normotensive W rats (W-C) and SHR-C, received vehicle
(0.2mL saline), and two treated groups, W-TE and SHR-TE,
received i.v. bolus of TE (100mg/kg b.w. dissolved in 0.2mL
saline).
2.3. Systemic Haemodynamic Measurements. For the direct
haemodynamic measurements, after bolus injection of TE
or vehicle, all rats were anesthetized with 35mg/kg b.w.
sodium pentobarbital, intraperitoneally. Mean arterial pres-
sure (MAP) and heart rate (HR) were measured through a
femoral artery catheter (PE–50, Clay-Adams Parsippany, NY,
USA), connected to a physiological data acquisition system
(Cardiomax III-TCR, Columbus Instruments, Columbus,
OH, USA). A jugular vein was cannulated with polyethylene
tubing PE-50 for the injection of solutions. The left carotid
artery was catheterized with a thermo sensor, which was
coupled to Cardiomax III for the determination of cardiac
output.The second end of thermocouple sensor was placed in
cold saline. Following 20min for stabilization after surgery,
rats were given a bolus injection of TE or vehicle, and
haemodynamic parameters were recorded 30 minutes after
injection. Cardiac output was normalized to body weight and
expressed as cardiac index (CI, mL/min/kg). Total peripheral
vascular resistance (TPVR, mmHg × min × kg/mL) was
calculated from MAP and CI (assuming that the mean right
atrial pressure is zero).
2.4. Regional Haemodynamic Measurements. For regional
blood flow measurements left carotid artery was gently
separated from the surrounding tissue. An ultrasonic flow
probe, 1RB (internal diameter = 1mm) was placed around the
artery and total carotid blood flow (CBF) was recorded using
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a Transonic T106 Small Animal Flowmeter (Transonic T106
Small Animal Flowmeter, Transonic System Inc., Ithaca, New
York). After abdominal incision renal artery preparation was
utilized and renal blood flow (RBF) was recorded. Vascular
resistance in these two vascular beds (CVR and RVR) was
calculated by dividing MAP with total blood flow through
respective blood vessel, normalized for the body weight, and
expressed as mmHg min kg/mL.
2.5. Plasma Sample and Tissue Isolation. Blood samples
obtained by puncture of the abdominal aorta were collected
under anaesthesia, 30minutes after TE or vehicle application,
into tubes containing lithium-heparin (Li-heparin, Sigma,
USA) as an anticoagulant. The plasma was separated by
centrifugation at 4000 rpm for 20min. After plasma remov-
ing, the remaining erythrocytes were rinsed three times,
aliquoted, and stored at −80∘C. Liver and kidney tissues
were removed immediately on ice, rinsed with cold saline,
weighed, and then cut into portions, frozen in liquid nitrogen,
and stored at−80∘C for the later estimation of protein content
and enzymatic antioxidant defence.
2.6. Enzyme-Linked Immunosorbent Assay for Heme
Oxygenase-1. Plasma and liver HO-1, an inducible heme
degrading enzyme with antioxidant properties, was detected
and quantified using commercially available, rat specific,
enzyme-linked immunosorbent assay kit (HO-1, rat, EIA.
ADI-EKS-810A, Enzo Life Sciences International, Inc.).
Plasma, previously stored at −20∘C, was defrosted and
in accordance with the manufacturer’s recommendations
prepared for analysis. On the day of analysis, tissue
was homogenized and prepared for the assay procedure
according to the manufacturer’s instructions. All samples,
including standard, were assayed in duplicate. The intensity
of the colour was measured in a microplate reader at 450 nm.
HO-1 concentrations from the sample were quantitated by
interpolating absorbance readings from a standard curve
generated with the calibrated HO-1 protein standard. Values
were expressed as ng/mL for plasma HO-1 and as 𝜇g/g of
liver tissue.
2.7. Heme Oxygenase Enzyme Activity. Plasma bilirubin
serves as a marker for heme oxygenase activity. Direct biliru-
bin (BIL-D) and total bilirubin (BIL-T) levels were deter-
mined using commercial kits for automatic analyser COBAS
INTEGRA 400 plus (Hoffmann-La Roche, Germany).
2.8. Superoxide Dismutase, Catalase, and Glutathione Per-
oxidase Enzyme Activities. Antioxidant enzyme activities
of the erythrocytes (e) as well as liver (L) and kidney
(k) homogenates were measured by following the spec-
trophotometric methods: catalase (CAT) was determined
as previously described [18], glutathione peroxidase (GPx)
was measured according to Paglia and Valentine [19], and
superoxide dismutase (SOD) was determined according to
McCord and Fridovich [20].
2.9. Lipid Peroxidation. For the assessment of lipid peroxi-
dation in plasma (p), liver (L), and kidney (k) lipid peroxide
levels were estimated by assaying thiobarbituric acid reac-
tive substances (TBARS) at 540 nm using 2-thiobarbituric
acid (4,6-dihydroxy-2-mercaptopyrimidine; TBA, Acros,
Organic). An extinction coefficient of 156000M−1 cm−1 was
used for calculation [21].The level of p-TBARS was expressed
as nmol/mL, while L-TBARS and k-TBARSwere expressed as
𝜇mol/g tissue.
2.10. Statistical Analysis. The data are given as mean ±
SEM.Comparisons between the respective groupsweremade
by using Student’s t-tests. 𝑝 values < 0.05 were considered
significant. Correlations between obtained parameters in
normotensive as well as in hypertensive rats were also
examined, and 𝑝 values < 0.05 were considered significant
(Statistica 8.0 for Windows).
3. Results
3.1. Effects of TE on Haemodynamic Parameters. Haemo-
dynamic parameters are shown in Figure 1. As expected,
MAP, HR, and TPVR of SHR-C were significantly higher
compared to the values of these parameters in W-C group
(𝑝 < 0.001), but without changes of CI. Bolus injection
of saline solution containing dry thyme extract resulted in
a significant decrease of MAP (𝑝 < 0.001) only in the
group of SHR-TE, while TPVR was reduced in both SHR-TE
(𝑝 < 0.01) and W-TE (𝑝 < 0.001) rats compared to their
respective controls (Figures 1(a) and 1(d)) without changes in
CI (Figure 1(c)). Injection of TE did not affect HR of both rat
strains (Figure 1(b)).
3.2. Effects of TE on Regional Haemodynamic Parameters.
Regional haemodynamic parameters are presented in Fig-
ure 2. The resistance in both vascular beds, carotid and renal
artery, were significantly elevated in SHR-C compared to W-
C (Figures 2(b) and 2(d), 𝑝 < 0.001 and 𝑝 < 0.05), without
changes of respective vascular blood flow (Figures 2(a) and
2(c)). Acute TE treatment led to a decrease of CBF inWistar
rats (Figure 2(a), 𝑝 < 0.05), while in the SHR caused a
significant reduction of CVR (Figure 2(b), 𝑝 < 0.05). Despite
marked reduction of MAP, RVR remained nonsignificantly
changed due to acute TE treatment (Figure 2(d)) but still
showed a tendency to get closer to W groups.
3.3. Effects of TE on Plasma and Liver HO-1 Enzyme Concen-
tration. We found that plasma HO-1 concentration did not
differ significantly between the examined groups, although
the value in SHR-TE group was the highest (Figure 3(a)).
The expression of liver HO-1 (Figure 3(b)) was lower in
hypertensive than in normotensive rats (1.32 ± 0.10 versus
1.62 ± 0.10mg/g tissue, 𝑝 = 0.0634). TE treatment signifi-
cantly increased the content of this enzyme in hypertensive
rats (SHR-TE, 1.66 ± 0.09, versus SHR-C, 1.32 ± 0.10mg/g
tissue, 𝑝 < 0.05). On the contrary, the application of TE
into normotensive rats resulted in a prominent decrease of
quantity of this enzyme (W-C: 1.62 ± 0.10 versus W-TE: 1.38
± 0.04mg/g tissue, 𝑝 = 0.0507).
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Figure 1: Haemodynamic parameters: (a) mean arterial pressure (MAP), (b) heart rate (HR), (c) cardiac index (CI), and (d) total peripheral
vascular resistance (TPVR) in experimental groups. W-C, normotensiveWistar rats, and SHR-C, spontaneously hypertensive rats, received
vehicle. W-TE and SHR-TE groups received thyme extract. ∗∗∗𝑝 < 0.001, the significant difference between SHR-C and W-C; ###𝑝 < 0.001,
##𝑝 < 0.01, and #𝑝 < 0.05, the significant difference between TE treated and appropriate control group.
3.4. Heme Oxygenase Enzyme Activity. Acute TE treatment
significantly increased plasma BIL-D level in both rat strains
(SHR-TE versus SHR-C: 𝑝 < 0.001; W-TE versus W-C: 𝑝 <
0.05, Figure 3(c)). Figure 3(d) shows that the plasma BIL-T
content was not significantly different in W rats. However,
the decreased BIL-T of hypertensive rats compared to age-
matched normotensive rats was significantly reversed by TE
treatment (SHR-TE versus SHR-C: 𝑝 < 0.05).
3.5. Effects of TE on Plasma, Liver, and Kidney Lipid Per-
oxidation. SHR-C had higher p-TBARS then W-C rats
(𝑝 = 0.0772, Figure 4(a)). Acute TE treatment significantly
reduced the level of p-TBARS in SHR-TE group compared
to SHR-C (𝑝 < 0.01, Figure 4(a)). On the contrary, in
normotensive rats the value of p-TBARS became almost
significantly elevated in response to TE treatment (𝑝 =
0.0625, Figure 4(a)). Liver homogenate TBARS levels did not
differ amongst W-C, SHR-C, and W-TE groups. However, L-
TBARS wasmarkedly increased in SHR-TE than that in SHR-
C group (𝑝 < 0.01 Figure 4(b)). The kidney TBARS level
was significantly lower in SHR-C group compared to theW-C
(𝑝 < 0.001 Figure 4(c)), and TE had no effects on it, in either
hypertensive or normotensive rats.
3.6. Effects of TE on Antioxidant Enzymes Activities in Ery-
throcytes, Liver, and Kidney. SOD, CAT, and GPx enzyme
activities in the erythrocytes, liver, and kidney from all
experimental animals are shown in Figure 5. There were no
differences in erythrocytes, liver, and kidney SOD activities
between SHR-C and W-C rats (Figures 5(a), 5(d), and 5(g)).
TE treatment significantly increased the kidney SOD activity
in the SHR (SHR-TE versus SHR-C: 𝑝 < 0.001), but not in
the W rats (Figure 5(g)). Erythrocytes and liver CAT activity
(Figures 5(b) and 5(e))was unchanged in SHR-C as compared
to W-C rats, but the treatment has led to the increases
of erythrocytes CAT activity only in SHR-TE compared to
SHR-C (𝑝 < 0.05). In contrast, CAT activity in kidney
(Figure 5(h)) was found to be increased in both W-TE and
SHR-C compared to W-C (𝑝 < 0.05, 𝑝 < 0.001, resp.).
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Figure 2: Regional haemodynamic parameters: (a) carotid blood flow (CBF), (b) carotid vascular resistance (CVR), (c) renal blood
flow (RBF), and (d) renal vascular resistance (RVR) in experimental groups. W-C, normotensive Wistar rats, and SHR-C, spontaneously
hypertensive rats, received vehicle. W-TE and SHR-TE groups received thyme extract. ∗𝑝 < 0.05 and ∗∗∗𝑝 < 0.001, the significant difference
between SHR-C and W-C; #𝑝 < 0.05, the significant difference between TE treated and appropriate control group.
GPx activity from the erythrocytes of SHR-Cwas significantly
lower compared to W-C (𝑝 < 0.01, Figure 5(c)). Bolus
injection of TE induced a significant elevation of kidney GPx
activities in normotensive rats (𝑝 < 0.05, Figure 5(i)). The
opposite effect was found in kidney homogenates of SHR
(Figure 5(e)). Namely, the activity of GPx was significantly
reduced in SHR-TE compared to SHR-C (𝑝 < 0.01). In the
liver homogenates the activity of this antioxidant enzymewas
unchanged in both W-TE and SHR-TE groups compared to
their controls (Figure 5(f)).
3.7. Correlation Analysis of Obtained Parameters. In SHR,
vascular resistance of the systemic circulation was found to
be positively correlated in relation to MAP (𝑟 = 0.7546, 𝑝 =
0.005), whereas in normotensive rats the negative correlation
of TPVR and CI (𝑟 = −0.8027, 𝑝 = 0.002) was observed.
Correlation between haemodynamic parameters and
oxidative status is shown inTable 1.MAP exhibits a significant
positive correlation with p-TBARS. Also, MAP and TPVR
showed strong negative correlation with regard to L-TBARS
and HO-1 expression and activity in hypertensive but not in
normotensive rats. In addition, in the group of hypertensive
rats, we found a significant positive intercorrelation between
L-TBARS, quantity of plasma and liver HO-1, and bilirubin
concentrations, followed by strong and negative intercorre-
lation between these parameters with p-TBARS, while in the
kidneywehave not found a correlation between the examined
parameters (Table 2). Table 3 represents the correlation of
antioxidant enzyme activity and systemic haemodynamic
parameters, with oxidative status in hypertensive and nor-
motensive rats.
4. Discussion
Earlier, we suggested that a powerful vasodilator molecule,
nitric oxide, is not liable for normalization of blood pressure
in TE treated SHR [7].
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Figure 3: The quantity of (a) plasma and (b) liver heme oxygenase-1 (HO-1), (c) direct bilirubin (BIL-D) in plasma, and (d) total plasma
bilirubin (BIL-T) in experimental groups. W-C, normotensive Wistar rats, and SHR-C, spontaneously hypertensive rats, received vehicle.
W-TE and SHR-TE groups received thyme extract. ###𝑝 < 0.001 and #𝑝 < 0.05, the significant difference between TE treated and appropriate
control group.


































































Figure 4: The quantity of (a) plasma (p), (b) liver (L), and (c) kidney (k) thiobarbituric acid reactive substances (TBARS) in experimental
groups. W-C, normotensive Wistar rats, and SHR-C, spontaneously hypertensive rats received vehicle. W-TE and SHR-TE groups received
thyme extract. ∗∗∗𝑝 < 0.001, the significant difference between SHR-C and W-C; ##𝑝 < 0.01, the significant difference between TE treated
and appropriate control group.





































































































































































































































































Figure 5: Antioxidant enzyme activities of (a), (b), and (c) erythrocytes, (d), (e), and (f) liver and (g), (h), and (i) kidney in experimental
groups. W-C, normotensiveWistar rats, and SHR-C, spontaneously hypertensive rats, received vehicle. W-TE and SHR-TE groups received
thyme extract, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). ∗𝑝 < 0.05 and ∗∗𝑝 < 0.01, the significant
difference between SHR-C and W-C; #𝑝 < 0.05 and ##𝑝 < 0.01, the significant difference between TE treated and appropriate control group.
Here, we hypothesized that induction of HO-1, due to
TE treatment, may contribute to powerful blood pressure-
lowering effect and reduction of systemic oxidative stress
in SHR. In support of our hypothesis are the results by Jin
et al. that identified rosmarinic acid as an inducer of HO-
1 expression by increasing ROS production in vitro [22].
Further evidence identifies derivate of caffeic acid, caffeic acid
phenethyl ester, as potent HO-1 inducer that can be used to
markedly increase heme oxygenase activity in astrocytes [23].
To our knowledge, the present study is the first showing TE-
induction of HO-1 in vivo, in hypertensive rats. Considering
all the above and the composition of used TE, we suggest that
this strong induction of HO-1 in SHR represents the response
of the liver to TE-induced increase of ROS production. This
assumption is supported with significant positive correlation
between liver ROSmeasured by TBARS and the level of HO-1
in hypertensive rats.
In the present study, wild thyme induced significant and
pronounced systemic vasorelaxation in both hypertensive
and normotensive rats compared to vehicle, but only in
hypertensive rats did such relaxation significantly and pos-
itively correlate with markedly reduced mean arterial pres-
sure. As expected, results from SHR showed increased TPVR,
CVR, and RVR accompanied with significant elevation of
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Table 2: The correlation of oxidative stress parameters with heme oxigenase-1 expression and activity in hypertensive (𝑛 = 12) and
normotensive rats (𝑛 = 12).
L-HO-1 HO-1 BIL-D BIL-T




















































SHR: spontaneously hypertensive rats that received vehicle or thyme extract; W:Wistar rats that received vehicle or thyme extract; L-TBARS, p-TBARS, and k-
TBARS: liver thiobarbituric acid reactive substance, plasma thiobarbituric acid reactive substance, and kidney thiobarbituric acid reactive substances; quantity
of L-HO-1 and p-HO-1: liver and plasma heme oxigenase-1 enzyme; BIL-D: direct bilirubin; BIL-T: total bilirubin. Marked correlations are significant at 𝑝 <
0.050.
Table 3: The correlation of antioxidant enzymes activity and systemic haemodynamic parameters, with oxidative status in hypertensive
(𝑛 = 12) and normotensive rats (𝑛 = 12).
e-CAT k-SOD k-CAT k-GPx



































































































SHR: spontaneously hypertensive rats that received vehicle or thyme extract;W:Wistar rats that received vehicle or thyme extract;MAP:mean arterial pressure;
TPVR: total peripheral vascular resistance; L-TBARS, p-TBARS, and k-TBARS: liver thiobarbituric acid reactive substance, plasma thiobarbituric acid reactive
substance, and kidney thiobarbituric acid reactive substance; BIL-D: direct bilirubin; e-CAT and k-CAT: erythrocyte catalase and kidney catalase; k-SOD:
kidney superoxide dismutase; k-GPx: kidney glutathione peroxidase. Marked correlations are significant at 𝑝 < 0.050.
blood pressure and HR, without changes of CI, CBF, or
RBF compared to Wistar rats. Our results in hypertensive
rats treated with TE are in favour of previously obtained
findings [24–26] that plant polyphenols decrease arterial
pressure in SHR. Some studies showed that upregulating the
HO/CO system lowers BP in young (8 weeks) but not in
adult (20 weeks) spontaneously hypertensive rats (SHR) [27].
Other studies have demonstrated that either acute or chronic
administration of HO-1 inducer was able to normalize blood
pressure in SHR and that heme administration decreased
blood pressure in SHR, while HO inhibitors produced an
increase in systemic arterial pressure, even in normoten-
sive rats [28]. The induction of HO-1 that we found in
hypertensive rats was in significant negative correlation with
the TPVR, indicating that HO-1 generated CO could be
accountable for the intensive systemic vasorelaxation and
the decrease of blood pressure that we observed in SHR-TE
group. These results are in accordance with reports in which,
like NO, HO-derived CO serves as a vasodilator to lower
blood pressure, regardless of whether it operates via cGMP-
dependent or cGMP-independent pathways, thus explaining
a number of the potential actions of CO regarding the
pathogenesis of cardiovascular diseases [28].This vasodilator
effect may also contribute to the improvement of regional
haemodynamics in the carotid artery of hypertensive rats.
The increased iron concentration produced by the HO-
1 activity is believed to cause the increased expression of
ferritin and ferritin synthesis, which serves to sequester iron,
a potent oxidant for cells [28]. Here, we did not determine
ferritin content, but there is evidence that tea polyphenols
could act as metal chelators [29] and therefore could remove
ferrous ions, thereby protecting cells against metal ion-
induced oxidative stress.
The next product of heme metabolism, biliverdin,
becomes cleaved by biliverdin reductase to bilirubin, a chain-
breaking antioxidant that acts as a lipid peroxyl radical
(ROO⋅) scavenger [16]. Bilirubin is toxic in high concen-
tration; however, it prevents adhesion molecule expression
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and neutrophil adhesion and inhibits ROS and NADPH
oxidase activity in biological systems [28]. Serum biliru-
bin circulates in the bloodstream in forms of direct and
indirect bilirubin and has potent endogenous antioxidant
properties that are found to have inverse associations with
cardiovascular disease [30]. At physiologic oxygen pressure,
bilirubin surpasses 𝛼-tocopherol, the most potent protector
against lipid peroxidation. Increased levels of serum TBARS
(a by-product of lipid peroxidation) have been previously
reported in SHR [31], as well as in patients with hypertension
and metabolic syndrome [32], ischemic heart disease [33],
peripheral arterial disease [34], and diabetes mellitus [35].
In the present study, along with slight plasma and marked
liver HO-1 elevation, plasma level of BIL-D became increased
and was followed by reduction of plasma lipid peroxidation
in SHR received TE. Also, there was significant negative
intercorrelation between the p-TBARS and liverHO-1, as well
as BIL-D, confirming the antioxidant defence properties of
these endogenous products.
Interestingly, the liver HO systemwas nearly significantly
suppressed in W-TE rats and that might be a possible reason
for a moderate increase of plasma lipid peroxidation in this
group.
The present study demonstrated almost similar SOD,
CAT, and GPx enzyme activity in the liver of all experimental
groups, which indicates that these antioxidant enzymes are
not crucial for the oxidative status of the liver. Reduced
activity of erythrocyte GPx from SHR in comparison to W
rats failed to become corrected with TE, but TE induced the
enhancement of erythrocyte CAT activity almost threefold
and therefore protected SHR against hydrogen peroxide
induced systemic oxidative stress. A similar kidney SOD
activity that we found in SHR and W rats was in accordance
with data obtained by Fortepiani and Reckelhoff [36] who
showed that the expression of kidney Mn-SOD and Cu
and Zn-SOD was similar in WKY and SHR despite higher
ability of hypertensive kidney to produce superoxide. Also,
they showed 30% lower expression of GPx and CAT in
SHR than WKY and that WKY had increased expression of
these enzymes in response to oxidative stress. We did not
measure the expression of previously mentioned enzymes,
but the activity of k-SOD that we observed was higher
after TE in SHR, but not in W rats. At the same time, k-
CAT and k-GPx enzyme activity was higher about 2-fold in
hypertensive than in normotensive kidney. Further, we found
the TE-induced increase of kidney CAT and GPx enzyme
activity in normotensive rats. These data indicate that the
increased activity of the k-CAT and k-GPx could have been
a compensatory mechanism for the prevention of moderate
plasma lipid peroxidation that we obtained in W-TE rats.
On the other hand, we found decreased activity of the
kidney GPx enzyme in hypertensive rats after TE. Conse-
quently, serum concentrations of bilirubin were high enough
to account for a substantial portion of the total antioxidant
capacity of serum [15], and bilirubin might alleviate oxidant
stress in the blood [14]; we could assume that bilirubin
ROO⋅ scavenging activity in our study is sufficient to avoid
oxidant stress in the hypertensive kidney. In addition to
the direct effects of TE on HO system, the increased k-
SOD activity due to the TE injection that we observed in
hypertensive rats could be accountable for normalization of
BP. Indeed, k-SOD was in significant negative correlation
withMAP andTVR in this rat strain, but not in normotensive
rats. Further, the increased k-SOD activity was in signifi-
cant negative association with GPx that in turn negatively
correlates against bilirubin, thus emphasizing the bilirubin
(regardless of whether it is total or direct) responsible for
plasma antioxidant defence.
The numerous polyphenolic substances and other chem-
ical compounds that were found in the plants from the Lami-
aceae family were speculated to account for the beneficial
effects of these plant extracts on the cardiovascular system.
However, the results of this experimental animal study indi-
cate that strong and significant hypotensive and antioxidative
activity of aqueous extract from Thymus serpyllum L. in
hypertensive rats, at least partially, resulted due to targeting
heme oxygenase system. Besides rosmarinic acid, used plant
extract contains caffeic acid and quercetin and luteolin in
trace [7]; thus further studies are needed to elucidate which
of these polyphenolic compounds is responsible for those
beneficial effects of TE or whether they are a consequence of
their synergistic action.
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Milanović et al., “Antioxidant and antihypertensive activity of
extract from Thymus serpyllum L. in experimental hyperten-
sion,” Plant Foods for Human Nutrition, vol. 68, no. 3, pp. 235–
240, 2013.
[8] M. S. Kumar, S. Kumar, and B. Raja, “Antihypertensive
and antioxidant potential of borneol-a natural terpene in L-
NAME—induced hypertensive rats,” International Journal of
Pharmaceutical and Biological Archive, vol. 1, pp. 271–279, 2010.
[9] K. Ohashi, T. Bohgaki, and H. Shibuya, “Antihypertensive
substance in the leaves of kumis kucing (Orthosiphon aristatus)
in Java island,” Yakugaku Zasshi, vol. 120, no. 5, pp. 474–482,
2000.
[10] Y.-I. I. Kwon, D. A. Vattem, and K. Shetty, “Evaluation of clonal
herbs of Lamiaceae species for management of diabetes and
hypertension,” Asia Pacific Journal of Clinical Nutrition, vol. 15,
no. 1, pp. 107–118, 2006.
[11] R. M. Touyz, “Reactive oxygen species, vascular oxidative
stress, and redox signaling in hypertension: what is the clinical
significance?” Hypertension, vol. 44, no. 3, pp. 248–252, 2004.
[12] A. L. Furfaro, N. Traverso, C. Domenicotti et al., “TheNrf2/HO-
1 axis in cancer cell growth and chemoresistance,” Oxidative
Medicine and Cellular Longevity, vol. 2016, Article ID 1958174,
14 pages, 2016.
[13] M. Mayer, “Association of serum bilirubin concentration with
risk of coronary artery disease,” Clinical Chemistry, vol. 46, no.
11, pp. 1723–1727, 2000.
[14] T. W. Sedlak and S. H. Snyder, “Bilirubin benefits: cellular pro-
tection by a biliverdin reductase antioxidant cycle,” Pediatrics,
vol. 113, no. 6, pp. 1776–1782, 2004.
[15] V. Lobo, A. Patil, A. Phatak, and N. Chandra, “Free radicals,
antioxidants and functional foods: impact on human health,”
Pharmacognosy Reviews, vol. 4, no. 8, p. 118, 2010.
[16] G. E. Mann, D. J. Rowlands, F. Y. L. Li, P. De Winter, and R.
C. M. Siow, “Activation of endothelial nitric oxide synthase by
dietary isoflavones: role of NO in Nrf2-mediated antioxidant
gene expression,” Cardiovascular Research, vol. 75, no. 2, pp.
261–274, 2007.
[17] J. F. Ndisang, L.Wu,W. Zhao, and R.Wang, “Induction of heme
oxygenase-1 and stimulation of cGMP production by hemin in
aortic tissues from hypertensive rats,” Blood, vol. 101, no. 10, pp.
3893–3900, 2003.
[18] E. Beutler, “Catalase,” in Red Cell Metabolism, a Manual of
Biochemical Methods, Grune and Stratton, New York, NY, USA,
3rd edition, 1982.
[19] D. E. Paglia and W. N. Valentine, “Studies on the quantitative
and qualitative characterization of erythrocyte glutathione per-
oxidase,” Journal of Laboratory and Clinical Medicine, vol. 70,
no. 1, pp. 158–169, 1967.
[20] J.M.McCord and I. Fridovich, “Theutility of superoxide dismu-
tase in studying free radical reactions. I. Radicals generated by
the interaction of sulfite, dimethyl sulfoxide, and oxygen,” The
Journal of Biological Chemistry, vol. 244, no. 22, pp. 6056–6063,
1969.
[21] H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides
in animal tissues by thiobarbituric acid reaction,” Analytical
Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
[22] C. H. Jin, H. S. Yang, D. S. Choi, M. W. Byun, W. G. Kim,
and I. Y. Jeong, “Rosmarinic acid attenuated SIN-1-induced
cytotoxicity in HepG2 cells through the HO-1 induction and
radical scavenging activity,” Food Science and Biotechnology, vol.
22, no. 2, pp. 549–556, 2013.
[23] G. Scapagnini, R. Foresti, V. Calabrese, A. M. Giuffrida Stella,
C. J. Green, and R. Motterlini, “Caffeic acid phenethyl ester
and curcumin: a novel class of heme oxygenase-1 inducers,”
Molecular Pharmacology, vol. 61, no. 3, pp. 554–561, 2002.
[24] J.-C. Liu, F.-L. Hsu, J.-C. Tsai et al., “Antihypertensive effects of
tannins isolated from traditional Chinese herbs as non-specific
inhibitors of angiontensin converting enzyme,” Life Sciences,
vol. 73, no. 12, pp. 1543–1555, 2003.
[25] N. Peng, J. T. Clark, J. Prasain, H. Kim, C. R. White, and J. M.
Wyss, “Antihypertensive and cognitive effects of grape polyphe-
nols in estrogen-depleted, female, spontaneously hypertensive
rats,”American Journal of Physiology. Regulatory, Integrative and
Comparative Physiology, vol. 289, no. 3, pp. R771–R775, 2005.
[26] S. J. Thandapilly, J. L. LeMaistre, X. L. Louis, C. M. Anderson,
T. Netticadan, and H. D. Anderson, “Vascular and cardiac
effects of grape powder in the spontaneously hypertensive rat,”
American Journal of Hypertension, vol. 25, no. 10, pp. 1070–1076,
2012.
[27] J. F. Ndisang, W. Zhao, and R. Wang, “Selective regulation of
blood pressure by heme oxygenase-1 in hypertension,” Hyper-
tension, vol. 40, no. 3, pp. 315–321, 2002.
[28] N. G. Abraham and A. Kappas, “Pharmacological and clinical
aspects of heme oxygenase,” Pharmacological Reviews, vol. 60,
no. 1, pp. 79–127, 2008.
[29] V. Stangl, H. Dreger, K. Stangl, and M. Lorenz, “Molecular
targets of tea polyphenols in the cardiovascular system,” Car-
diovascular Research, vol. 73, no. 2, pp. 348–358, 2007.
[30] J. Jo, J. E. Yun, H. Lee, H. Kimm, and S. H. Jee, “Total, direct,
and indirect serum bilirubin concentrations and metabolic
syndrome among the Korean population,” Endocrine, vol. 39,
no. 2, pp. 182–189, 2011.
[31] M. A. Newaz and N. N. A. Nawal, “Effect of 𝛾-tocotreenol
on blood pressure, lipid peroxtoation and total antioxtoant
status in spontaneously hypertensive rats (SHR),” Clinical and
Experimental Hypertension, vol. 21, no. 8, pp. 1297–1313, 1999.
[32] V. O. Palmieri, I. Grattagliano, P. Portincasa, and G. Palasciano,
“Systemic oxidative alterations are associated with visceral adi-
posity and liver steatosis in patients with metabolic syndrome,”
The Journal of Nutrition, vol. 136, no. 12, pp. 3022–3026, 2006.
[33] B. R. Maharjan, J. C. Jha, D. Adhikari et al., “Oxidative stress,
antioxidant status and lipid profile in ischemic heart disease
patients from western region of Nepal,” Nepal Medical College
Journal, vol. 10, no. 1, pp. 20–24, 2008.
[34] J. Miquel, A. Ramirez-Bosca, A. Soler et al., “Increase with age
of serum lipid peroxides: implications for the prevention of
atherosclerosis,” Mechanisms of Ageing and Development, vol.
100, no. 1, pp. 17–24, 1998.
[35] A. A. Osuntokl, O. A. Fasanmade, A. O. Adekola, and C. O.
Amira, “Lipid peroxidation and erythrocyte fragility in poorly
controlled type 2 diabetes mellitus,” Nigerian Quarterly Journal
of Hospital Medicine, vol. 17, no. 4, pp. 148–151, 2007.
[36] L. A. Fortepiani and J. F. Reckelhoff, “Increasing oxidative
stress with molsidomine increases blood pressure in genetically
hypertensive rats but not normotensive controls,” American
Journal of Physiology—Regulatory Integrative and Comparative
Physiology, vol. 289, no. 3, pp. R763–R770, 2005.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
